drugset / Trial / NCT01076322

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients

NCT01076322

Phase 3 Completed 17 enrolled Taiwan Otsuka Pharm. Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

This is an open-label, randomized, cross-over, active-controlled study to evaluate the efficacy and safety effects using Meptin® Swinghaler and Ventolin® MDI in stable asthma patients.

Timeline

Start
2009-03
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Procaterol Other / unclassified 10 g Inhaled
Subject Salbutamol Unknown 100 g Inhaled

Indications